About Calibrium
Calibrium is a company based in Zurich (Switzerland) founded in 2006 by Richard DiMarchi and Fritz French was acquired by Novo Nordisk in August 2015.. Calibrium has raised $1.7 million across 1 funding round from investors including Novo Nordisk, Frazier Healthcare Partners and 5AM Ventures. Calibrium operates in a competitive market with competitors including Sana Biotechnology, Kriya Therapeutics, Semma Therapeutics, Cellino and Adocia, among others.
- Headquarter Zurich, Switzerland
- Founders Richard DiMarchi, Fritz French
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.7 M (USD)
in 1 rounds
-
Latest Funding Round
$1.7 M (USD), Seed
Dec 20, 2013
-
Investors
Novo Nordisk
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Novo Nordisk
(Aug 27, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Calibrium
Calibrium has successfully raised a total of $1.7M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.7 million completed in December 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.7M
-
First Round
First Round
(20 Dec 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2013 | Amount | Seed - Calibrium | Valuation | Frazier Healthcare Partners , 5AM Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Calibrium
Calibrium has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Novo Nordisk, Frazier Healthcare Partners and 5AM Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Founded Year | Domain | Location | |
|
BioCrossroads is focused on advancing Indiana's life sciences industry.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Calibrium
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Calibrium
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Calibrium Comparisons
Competitors of Calibrium
Calibrium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Kriya Therapeutics, Semma Therapeutics, Cellino and Adocia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Calibrium
When was Calibrium founded?
Calibrium was founded in 2006 and raised its 1st funding round 7 years after it was founded.
Where is Calibrium located?
Calibrium is headquartered in Zurich, Switzerland.
Who is the current CEO of Calibrium?
Fritz French is the current CEO of Calibrium. They have also founded this company.
Is Calibrium a funded company?
Calibrium is a funded company, having raised a total of $1.7M across 1 funding round to date. The company's 1st funding round was a Seed of $1.7M, raised on Dec 20, 2013.
What does Calibrium do?
Calibrium was founded in 2006 and is based in Zurich, Switzerland. Focus is placed on the discovery and early development of peptide-based therapies targeting diabetes and related metabolic diseases. Operations center on advancing these treatments through preclinical stages within the biotechnology sector. Leadership includes co-founders Richard DiMarchi and Fritz French, with Bernd Kammerlander serving as CEO.
Who are the top competitors of Calibrium?
Calibrium's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
Who are Calibrium's investors?
Calibrium has 4 investors. Key investors include Novo Nordisk, Frazier Healthcare Partners, 5AM Ventures, and BioCrossroads.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.